Sophorolipid-toluidine blue conjugates for improved antibacterial photodynamic therapy through high accumulation

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Sophorolipid-toluidine blue conjugates for improved antibacterial photodynamic therapy through high accumulation

Abstract: Triple structural factors, including sophorose affinity to envelope, hydrophobic association with membrane and electrostatic attraction, have contributed to enhanced antibacterial photodynamic therapy of sophorolipid conjugated toluidine blue.

Cited by 3 publications

References 41 publications

Exploring the biofilm inhibitory potential of Candida sp. UFSJ7A glycolipid on siliconized latex catheters

Exploring the biofilm inhibitory potential of Candida sp. UFSJ7A glycolipid on siliconized latex catheters

Toluidine blue O photosensitizer combined with caffeic acid improves antibacterial performance by increasing the permeability of cell membrane

Tertiary/quaternary amine derivatives of sophorolipid for baicalin solubility and antioxidating performance improvement: solubilization or hydrotropy?

Contact Info

Product

Resources

About